Connect with us

Hi, what are you looking for?

Editor's Pick

Eli Lilly stock surges 11% on obesity pill’s success in first late-stage trial

Eli Lilly’s experimental obesity pill, orforglipron, met its main goals in a closely watched late-stage trial, boosting the company’s standing in the fast-growing market...

16 hours ago

Editor's Pick

ECB cuts rates by 25 bps as inflation eases, but warns trade tensions cloud growth outlook

The European Central Bank on Thursday reduced its key interest rate by 25 basis points, citing easing inflation and mounting risks to economic growth...

16 hours ago
More Posts

    Disclaimer: Bullsmarketdominators.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 Bullsmarketdominators.com